Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax (Q47892124)

6 February 2018

title

Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax (English)

1 reference

6 February 2018

0 references

0 references

0 references

1 reference

Christian F Ockenhouse

9

object named as

Christian F Ockenhouse

1 reference

6 February 2018

author name string

Brian A Bell

1

1 reference

6 February 2018

James F Wood

2

1 reference

6 February 2018

Reeta Bansal

3

1 reference

6 February 2018

Hatem Ragab

4

1 reference

6 February 2018

John Cargo

5

1 reference

6 February 2018

Michael A Washington

6

1 reference

6 February 2018

Chloe L Wood

7

1 reference

6 February 2018

Lisa A Ware

8

1 reference

6 February 2018

Anjali Yadava

10

1 reference

6 February 2018

language of work or name

English

0 references

publication date

10 January 2009

1 reference

6 February 2018

published in

Vaccine

1 reference

6 February 2018

volume

27

1 reference

6 February 2018

issue

9

1 reference

6 February 2018

page(s)

1448-1453

1 reference

6 February 2018

Vivax malaria: neglected and not benign

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.027

Neglect of Plasmodium vivax malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.027

Circumsporozoite proteins of malaria parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.027

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.027

Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.027

Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.027

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.027

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.027

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.027

An update on the search for a Plasmodium vivax vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.027

Safety and elicitation of humoral and cellular responses in colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.027

Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.027

A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.027

Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.027

The process development challenge for a new vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.027

10.1016/J.VACCINE.2008.12.027

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

release_33jzti6uifce7pbydxjwyebc6a

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/33jzti6uifce7pbydxjwyebc6a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

6 February 2018